“The present circumstance has uncovered some structural weaknesses during the EU’s medicines provide chain and also a significant dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides explained. She encouraged that supply chain challenges be dealt with within an EU pharmaceutical method predicted to generally be intr